The Small Saphenous Vein: An Underestimated Source for Autologous Distal Vein Bypass.
Adolescent
Adult
Aged
Aged, 80 and over
Austria
Female
Humans
Limb Salvage
Male
Middle Aged
Peripheral Arterial Disease
/ diagnostic imaging
Postoperative Complications
/ mortality
Retrospective Studies
Risk Assessment
Risk Factors
Saphenous Vein
/ diagnostic imaging
Time Factors
Transplantation, Autologous
Treatment Outcome
Vascular Grafting
/ adverse effects
Vascular Patency
Young Adult
Alternative vein bypass
Peripheral artery disease
Peripheral vein bypass
Small saphenous vein
Journal
European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery
ISSN: 1532-2165
Titre abrégé: Eur J Vasc Endovasc Surg
Pays: England
ID NLM: 9512728
Informations de publication
Date de publication:
Oct 2019
Oct 2019
Historique:
received:
19
12
2017
accepted:
22
01
2019
pubmed:
3
3
2019
medline:
9
4
2020
entrez:
3
3
2019
Statut:
ppublish
Résumé
The small saphenous vein (SSV) is a potential vein source for bypass if neither greater saphenous vein nor arm vein is available. This study reports experience using SSV as part of an all autologous vein bypass policy. This study comprised single centre retrospective data analysis of all consecutive patients treated at an academic tertiary referral centre from January 1998 to February 2017 using the SSV as the main peripheral bypass graft. Study endpoints were primary patency, secondary patency, limb salvage, and survival. One hundred and twenty operations were performed in 118 patients using SSV. Indications were peripheral arterial occlusive disease (n = 91; Rutherford classification 3: n = 11; 4: n = 21; 5,6: n = 59), acute ischaemia (n = 14), popliteal artery aneurysm (n = 12), and bypass revisions (n = 3). Median follow up was 30.5 months (10 months-13.7 years). Primary patency after one, three and five years was 68% (CI: 59-77%), 58% (49-68%), and 54% (45-64%). Secondary patency was 83% (76-89%) after one year and 77% (69-85%) after three and five years. Limb salvage after one year was 88% (82-94%) and 78% (70-86%) after five years. Survival was 96% (92-99%) after one year and 91% (85-97%) at five years. Multivariable analysis identified redo surgery as an independent risk factor. Patients receiving a primary (n = 59) vs. a redo bypass (n = 61) were compared. Primary patency and secondary patency were both significantly better in the primary bypass group than in the redo group (p = .0036 and p = .0003, respectively). Limb salvage was also significantly better in primary bypass patients than in the redo group (p = .0007), whereas overall survival did not differ significantly (p = .48). The SSV is a valuable alternative vein graft in peripheral bypass surgery. It achieves excellent long-term results, particularly in patients with primary procedures but also acceptable results in patients with redo surgery.
Identifiants
pubmed: 30824403
pii: S1078-5884(19)30054-1
doi: 10.1016/j.ejvs.2019.01.023
pii:
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
556-563Commentaires et corrections
Type : CommentIn
Informations de copyright
Copyright © 2019 European Society for Vascular Surgery. Published by Elsevier B.V. All rights reserved.